Trial
NCT04196010
Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Washington
Collaborators
—
Condition
Myeloid Neoplasm
Intervention
Cladribine
Why stopped
Terminated due to unfavorable risk-benefit ratio of investigational regimen.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-28